The Forschungszentrum Dresden-Rossendorf Chooses NanoSight to Characterize Magnetic Nanoparticles

The Institute for Radiopharmacy at the Forschungszentrum Dresden-Rossendorf is using NanoSight's LM-20 nanoparticle characterization system to study magnetic nanoparticles for applications in cancer therapy.

Related Posts

Comments are closed.